We’ve had a China IPO this week and couple of biotechs … Macau and “in certain circumstances” Taiwan. Its partnerships are with Tesaro, Paratek (PRTK) and Bristol-Myers Squibb (BMY). There is the aforementioned niraparib, which is in Phase III …
( read original story …)